metformin has been researched along with Adenosis of Breast in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alipour, S | 1 |
| Rastad, H | 1 |
| Saberi, A | 1 |
| Faiz, F | 1 |
| Maleki-Hajiagha, A | 1 |
| Abedi, M | 1 |
| Talaei, A | 1 |
| Moradi, A | 1 |
| Rafiei, F | 1 |
2 trials available for metformin and Adenosis of Breast
| Article | Year |
|---|---|
Metformin in the management of fibrocystic breast disease: a placebo-controlled randomized clinical trial.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Female; Fibrocystic | 2021 |
The evaluation of the effect of metformin on breast fibrocystic disease.
Topics: Adolescent; Adult; AMP-Activated Protein Kinases; Double-Blind Method; Female; Fibrocystic Breast Di | 2017 |